Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Natural Medicine Institute Of Zhejiang Yangshengtang Co. Ltd. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are handled by 2 distinct examiners and are located within 2 distinct art units. This indicates that the company's current patent applications are being reviewed by various specialized entities.
The busiest examiner identified is STONEBRAKER, ALYSSA RAE, who manages 1 busiest examiner pending office action. Since the total 2 pending office actions are divided among different examiners, the applicant must manage separate prosecution tracks. This requires a strategy that can address the specific feedback from each examiner independently.
With 2 distinct art units involved, the company's prosecution efforts are subject to the varied practices of different office divisions. Each active matter faces its own set of technical and procedural hurdles. Practitioners must be prepared to navigate the nuances of these 2 distinct art units to achieve successful outcomes.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STONEBRAKER, ALYSSA RAE | 1 | 58.3% | +49.2% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 46.9% | +81.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915326 | PHARMACEUTICAL COMBINATION AND USE THEREOF | JOHNSON, CHRISTOPHER LINDSAY | 3d overdue |
| 18262475 | COMPOSITION AND METHOD FOR TREATING TUMORS | STONEBRAKER, ALYSSA RAE | — |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18262475 | COMPOSITION AND METHOD FOR TREATING TUMORS | STONEBRAKER, ALYSSA RAE | 1642 | §103 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 17915326 | PHARMACEUTICAL COMBINATION AND USE THEREOF | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 3d overdue | Pending | Sep 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial